Abdinasir Abubakar

Abdinasir Abubakar

Auto-generated profile, based on publicly available information

Abdinasir Abubakar

WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in The Lancet
Verified
Journal Article
Closed access
ASAhmed Mohammed Obaid Al Saidi
Ahmed Mohammed Obaid Al Saidi
FNFowsiya Abikar Nur
Fowsiya Abikar Nur
AAAhmed Salim Al-Mandhari
Ahmed Salim Al-Mandhari
MRMaha El Rabbat
Maha El Rabbat
AHAssad Hafeez
Assad Hafeez
AAAbdinasir Abubakar
Abdinasir Abubakar

20 May 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
QZQulu Zheng
Qulu Zheng
FLFrancisco J Luquero
Francisco J Luquero
ICIza Ciglenecki
Iza Ciglenecki
JWJoseph F Wamala
Joseph F Wamala
AAAbdinasir Abubakar
Abdinasir Abubakar
ELElizabeth C Lee
Elizabeth C Lee
Cholera remains a public health threat but is inequitably distributed across sub-Saharan Africa. Lack of standardized reporting and inconsistent outbreak definitions limit our understanding of cholera outbreak epidemiology. From a database of cholera incidence and mortality, we extracted data from sub-Saharan Africa and reconstructed outbreaks of suspected cholera starting in January 2010 to December 2019 based on location-specific average weekly incidence rate thresholds. We then described the distribution of key outbreak metrics. We identified 999 suspected cholera outbreaks in 744 regions across 25 sub-Saharan African countries. The outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 to January 2020. Among 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1000 people (interquartile range (IQR), 0.3-2.4 per 1000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks. This study provides a baseline from which the progress toward cholera control and essential statistics to inform outbreak management in sub-Saharan Africa can be monitored.

6 March 2021 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
PDF file
EMEhsan Mostafavi
Ehsan Mostafavi
AGAbdolmajid Ghasemian
Abdolmajid Ghasemian
AAAbubakar Abdinasir
Abubakar Abdinasir
SMSeyed Alireza Nematollahi Mahani
Seyed Alireza Nematollahi Mahani
SRSalman Rawaf
Salman Rawaf
ASAlexandra Swaka
Alexandra Swaka
Background: Countries in the World Health Organization (WHO) Eastern Mediterranean Region (EMR) are predisposed to highly contagious, severe and fatal, emerging infectious diseases (EIDs), and re-emerging infectious diseases (RIDs). This paper reviews the epidemiological situation of EIDs and RIDs of global concern in the EMR between 2001 and 2018. Methods: To do a narrative review, a complete list of studies in the field was we prepared following a systematic search approach. Studies that were purposively reviewed were identified to summarize the epidemiological situation of each targeted disease. A comprehensive search of all published studies on EIDs and RIDs between 2001 and 2018 was carried out through search engines including Medline, Web of Science, Scopus, Google Scholar, and ScienceDirect. Results: Leishmaniasis, hepatitis A virus (HAV) and hepatitis E virus (HEV) are reported from all countries in the region. Chikungunya, Crimean Congo hemorrhagic fever (CCHF), dengue fever, and H5N1 have been increasing in number, frequency, and expanding in their geographic distribution. Middle East respiratory syndrome (MERS), which was reported in this region in 2012 is still a public health concern. There are challenges to control cholera, diphtheria, leishmaniasis, measles, and poliomyelitis in some of the countries. Moreover, Alkhurma hemorrhagic fever (AHF), and Rift Valley fever (RVF) are limited to some countries in the region. Also, there is little information about the real situation of the plague, Q fever, and tularemia. Conclusion: EIDs and RIDs are prevalent in most countries in the region and could further spread within the region. It is crucial to improve regional capacities and capabilities in preventing and responding to disease outbreaks with adequate resources and expertise.

1 March 2020 in Journal of Infection and Public Health
Verified
Journal Article
Open access
MEMohamed Elhakim
Mohamed Elhakim
MRMohammad Hafiz Rasooly
Mohammad Hafiz Rasooly
MFManal Fahim
Manal Fahim
SASami Sheikh Ali
Sami Sheikh Ali
NHNadine Haddad
Nadine Haddad
SMSk. Md. Mamunur R. Malik
Sk. Md. Mamunur R. Malik
Influenza surveillance systems in the Eastern Mediterranean Region have been strengthened in the past few years and 16 of the 19 countries in the Region with functional influenza surveillance systems report their influenza data to the EMFLU Network. This study aimed to investigate the epidemiology of circulating influenza viruses, causing SARI, and reported to the EMFLU during July 2016 to June 2018. Data included in this study were collected by 15 countries of the Region from 110 SARI sentinel surveillance sites over two influenza seasons. A total of 40,917 cases of SARI were included in the study. Most cases [20,551 (50.2%)] were less than 5years of age. Influenza virus was detected in 3995 patients, 2849 (11.8%) were influenza A and 1146 (4.8%) were influenza B. Influenza A(H1N1)pdm09 was the predominant circulating subtype with 1666 cases (58.5%). Other than influenza, respiratory syncytial virus was the most common respiratory infection circulating, with 277 cases (35.9%). Influenza viruses cause a high number of severe respiratory infections in EMR. It is crucial for the countries to continue improving their influenza surveillance capacity in order detect any unusual influenza activity or new strain that may cause a pandemic.

1 July 2019 in Journal of Infection and Public Health
Verified
Journal Article
Open access
HZHassan Zaraket
Hassan Zaraket
NMNada Melhem
Nada Melhem
MMMamunur Malik
Mamunur Malik
WKWasiq M. Khan
Wasiq M. Khan
Ghassan DbaiboGhassan Dbaibo
Ghassan Dbaibo
AAAbdinasir Abubakar
Abdinasir Abubakar
Vaccination is the main control measure for influenza and its severe complications. To better understand the influenza vaccination situation in the Eastern Mediterranean Region, we conducted an extensive review of literature published between 2006 and 2016 in the region on influenza vaccine policies, use, recommendations and coverage. Forty-eight articles met the inclusion criteria. These originated from 11 of the 22 countries of the region, with most being from Saudi Arabia and Iran. The review revealed knowledge gaps and misconceptions about influenza and its vaccines even among healthcare workers. Most of the papers reviewed reported low coverage in the target populations. Limited literature on the number of countries with concrete national influenza vaccination policies was available, which may not accurately represent the situation in the Region. In conclusion, lack of awareness and knowledge are the main barriers to influenza vaccination, which remains very low in the Eastern Mediterranean Region. Countries of the region need to promote and invest in research on influenza vaccination, which is critical to inform evidence-based programmes and policies to improve vaccination rates and control influenza.

6 November 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
SASalah Al Awaidy
Salah Al Awaidy
Zayid Al MayahiZayid Al Mayahi
Zayid Al Mayahi
MKMalak Kaddoura
Malak Kaddoura
OMozayr mahomed
ozayr mahomed
NLNathalie Lahoud
Nathalie Lahoud
HZHassan Zaraket
Hassan Zaraket
Background: Seasonal influenza infections are a major cause of morbidity and mortality worldwide. Healthcare workers (HCWs) are an important target group for vaccination against influenza due to their increased risk of infection and their potential to transmit the infection to their patients, families and communities. The aim of this study was to assess the potential hesitancy and its associated factors towards influenza vaccination amongst HCWs in the South Al Batinah governorate in Oman. Methods: A cross-sectional survey of 390 HCWs with direct or indirect patient contact was conducted in May and June 2019 using a self-administered questionnaire. Associations between HCW characteristics and vaccination status were examined using bivariate and multivariate analyses to identify the likelihood of vaccination against seasonal influenza among HCWs. Results: Overall, 60% of HCWs were vaccinated in the 2018/2019 season; vaccine uptake among nurses was 52% and uptake was higher among women. Self-protection and protection of the community were the most cited reasons for vaccine acceptance, with side effects being the main reason for hesitancy. Vaccinated respondents had a higher mean knowledge score (7.18; standard deviation SD: 2.14) than unvaccinated respondents (6.30; SD: 2.2). Odds of vaccination were highest among respondents who believed influenza vaccine should be mandatory for HCWs (Odds ratio (OR): 2.04 [1.30–3.18]), those working in the general medicine, emergency medicine, or intensive care units (OR: 1.92 [1.20–3.10]), nurses and doctors (OR: 1.75 [1.09–2.79]) and those who believe that HCWs should receive an influenza vaccine (OR: 1.35 [1.07–2.77]). Conclusions: The study provides valuable insights into the enablers and barriers of influenza vaccination practices among HCWs and may inform interventions to increase acceptance of vaccination.